Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress via modulation of Keap1/Nrf2 signaling pathway

References

• Dugbartey GJ, Peppone LJ, De Graaf IA. An integrative view of cisplatin-induced renal and cardiac toxicities: molecular mechanisms, current treatment challenges and potential protective measures. Toxicology. 2016;371:58–66.
   PubMed Web of Science ®Google Scholar
• Guglin M, Aljayeh M, Saiyad S, et al. Introducing a new entity: chemotherapy-induced arrhythmia. Europace. 2009;11(12):1579–1586.
   PubMedGoogle Scholar
• Schrier RW, Wang W, Poole B, et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114(1):5–14.
   PubMed Web of Science ®Google Scholar
• Shen DW, Pouliot LM, Hall MD, et al. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64(3):706–721.
   PubMed Web of Science ®Google Scholar
• El-Awady El SE, Moustafa YM, Abo-Elmatty DM, et al. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol. 2011;650(1):335–341.
   PubMed Web of Science ®Google Scholar
• Nabeebaccus A, Zhang M, Shah AM. NADPH oxidases and cardiac remodelling. Heart Fail Rev. 2011;16(1):5–12.
   PubMedGoogle Scholar
• Lin ZJ, Bao YY, Hong B, et al. Salvianolic acid B attenuated cisplatin-induced cardiac injury and oxidative stress via modulating Nrf2 signal pathway. J Toxicol Sci. 2021;46(5):199–207.
   PubMed Web of Science ®Google Scholar
• Joo MS, Kim WD, Lee KY, et al. AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550. Mol Cell Biol. 2016;36(14):1931–1942.
   PubMed Web of Science ®Google Scholar
• Ashabi G, Khalaj L, Khodagholi F, et al. Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab Brain Dis. 2015;30(3):747–754.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang H, Cao Y, et al. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways. Drug Des Devel Ther. 2017;11:2179–2191.
   PubMed Web of Science ®Google Scholar
• Zhang L, Guo Z, Wang Y, et al. The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats. Drug Dev Res. 2019;80(3):294–309.
   PubMed Web of Science ®Google Scholar
• Han J, Shi X, Du Y, et al. Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in ang II-challenged vascular endothelium. Phytother Res. 2019;33(3):779–790.
   PubMedGoogle Scholar
• Shan Y, Jiang B, Yu J, et al. Protective effect of schisandra chinensis polysaccharides against the immunological liver injury in mice based on Nrf2/ARE and TLR4/NF-κB signaling pathway. J Med Food. 2019;22(9):885–895.
   PubMedGoogle Scholar
• Ji QQ, Li YJ, Wang YH, et al. Salvianolic acid B improves postresuscitation myocardial and cerebral outcomes in a murine model of cardiac arrest: involvement of Nrf2 signaling pathway. Oxid Med Cell Longevity. 2020;2020:1–17.
   Google Scholar
• Jin YM, Tao XM, Shi YN, et al. Salvianolic acid B exerts a protective effect in acute liver injury by regulating the Nrf2/HO-1 signaling pathway. Can J Physiol Pharmacol. 2020;98(3):162–168.
   PubMedGoogle Scholar
• Ramyaa P, Krishnaswamy R, Padma VV. Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells – up regulation of Nrf2 expression and down regulation of NF-κB and COX-2. Biochim Biophys Acta. 2014;1840(1):681–692.
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.
   PubMed Web of Science ®Google Scholar
• Yang PW, Lu ZY, Pan Q, et al. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1. Phytomedicine. 2019;57:18–29.
   PubMed Web of Science ®Google Scholar
• Fei J, Liang B, Jiang C, et al. Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacother. 2019;109:1586–1592.
   PubMed Web of Science ®Google Scholar
• Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol. 1996;27(4):713–722.
   PubMedGoogle Scholar
• Fan X, Du K, Li N, et al. Evaluation of anti-Nociceptive and anti-inflammatory effect of luteolin in mice. J Environ Pathol Toxicol Oncol. 2018;37(4):351–364.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu P, Yu H, et al. Luteolin protects PC-12 cells from H2O2-induced injury by up-regulation of microRNA-21. Biomed Pharmacother. 2019;112:108698.
   PubMed Web of Science ®Google Scholar
• Li L, Luo W, Qian YY, et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-kappa B-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine. 2019;59:152774.
   PubMed Web of Science ®Google Scholar
• Boeing T, De Souza P, Speca S, et al. Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties. Br J Pharmacol. 2020;177(10):2393–2408.
   PubMed Web of Science ®Google Scholar
• Zhang P, Yi LH, Meng GY, et al. Apelin-13 attenuates cisplatin-induced cardiotoxicity through inhibition of ROS-mediated DNA damage and regulation of MAPKs and AKT pathways. Free Radic Res. 2017;51(5):449–459.
   PubMed Web of Science ®Google Scholar
• Qian P, Yan LJ, Li YQ, et al. Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis. Exp Ther Med. 2018;15(2):1959–1965.
   PubMed Web of Science ®Google Scholar
• Zhao L. Protective effects of trimetazidine and coenzyme Q10 on cisplatin-induced cardiotoxicity by alleviating oxidative stress and mitochondrial dysfunction. Anatol J Cardiol. 2019;22(5):232–239.
   PubMed Web of Science ®Google Scholar
• Lv LH, Lv LH, Zhang YB, et al. Luteolin prevents LPS-Induced TNF-α expression in cardiac myocytes through inhibiting NF-κB signaling pathway. Inflammation. 2011;34(6):620–629.
   PubMedGoogle Scholar
• Chang H, Li C, Huo KY, et al. Luteolin prevents H2O2-Induced apoptosis in H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway. Biomed Res Int. 2016;2016:5125836.
   PubMedGoogle Scholar
• Yao H, Shang ZM, Wang PH, et al. Protection of luteolin-7-O-Glucoside against Doxorubicin-Induced injury through PTEN/akt and ERK pathway in H9c2 cells. Cardiovasc Toxicol. 2016;16(2):101–110.
   PubMedGoogle Scholar
• Shi YY, Li FF, Shen M, et al. Luteolin prevents cardiac dysfunction and improves the chemotherapeutic efficacy of doxorubicin in breast cancer. Front Cardiovasc Med. 2021;8:750186.
   PubMedGoogle Scholar
• Jayasuriya R, Dhamodharan U, Ali D, et al. Targeting Nrf2/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease. Phytomedicine. 2021;92:153755.
   PubMedGoogle Scholar
• Al-Majed AA, Sayed-Ahmed MM, Al-Yahya AA, et al. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol Res. 2006;53(3):278–286.
   PubMedGoogle Scholar
• Raja W, Mir MH, Dar I, et al. Cisplatin induced paroxysmal supraventricular tachycardia. Indian J Med Paediatr Oncol. 2013;34(4):330–332.
   PubMedGoogle Scholar
• Ma H, Jones KR, Guo R, et al. Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: role of endoplasmic reticulum stress. Clin Exp Pharmacol Physiol. 2010;37(4):460–465.
   PubMedGoogle Scholar
• Topal I, Ozbek Bilgin A, Keskin CF, et al. The effect of rutin on cisplatin-induced oxidative cardiac damage in rats. Anatol J Cardiol. 2018;20(3):136–142.
   PubMed Web of Science ®Google Scholar
• Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–426.
   PubMed Web of Science ®Google Scholar
• Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47(9):1304–1309.
   PubMed Web of Science ®Google Scholar
• Calvert JW, Jha S, Gundewar S, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009;105(4):365–374.
   PubMed Web of Science ®Google Scholar
• Xiao C, Xia ML, Wang J, et al. Luteolin attenuates cardiac ischemia/reperfusion injury in diabetic rats by modulating Nrf2 antioxidative function. Oxid Med Cell Longev. 2019;2019:2719252.
   PubMedGoogle Scholar
• Farooqi AA, Butt G, El-Zahaby SA, et al. Luteolin mediated targeting of protein network and microRNAs in different cancers: focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways. Pharmacol Res. 2020;160:105188.
   PubMedGoogle Scholar
• Tan XH, Zhang KK, Xu JT, et al. Luteolin alleviates methamphetamine-induced neurotoxicity by suppressing PI3K/Akt pathway-modulated apoptosis and autophagy in rats. Food Chem Toxicol. 2020;137:111179.
   PubMedGoogle Scholar